Latest News
GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline Pharmaceuticals Q2 2026 Earnings: Steady Top-Line Growth and a ₹61.15 Per-Share Print Keep the Stock Firmly in Positive - Earnings Revision Report
- GlaxoSmithKline Pharmaceuticals (NSE:GLAXO): What Did the Q2 FY27 Share Capital Audit Reveal?
- GlaxoSmithKline Pharmaceuticals (GLAXO.NS) Eases 1.08% to ₹2504.1 as Stock Holds Above Key Support - Dollar Neutral Pair
- GlaxoSmithKline Pharmaceuticals (NSEI:GLAXO) Stock Forecast & Analyst Predictions
- Glaxosmithkline Pharmaceuticals (GLAXO) Share Price Fall Streak Continues for Second Straight Session
- Glaxosmithkline Pharmaceuticals Share Price rises 4.17%
Headlines from the last 30 days, linking to the original publishers. See all market news →